Publications

5897 Results

Composition of Health Care Contact Days and Mortality Prediction Among Older Adult Clinical Trial Participants

Authors
Gupta A;Till C;LeBlanc ML;Hershman DL;Unger JM
Journal / Conference
JCO Oncology Practice. 2026 Apr 1; OP-25-01182. DOI: 10.1200/OP-25-01182.
Year
2026
Research Committee(s)
Cancer Care Delivery
PMID
41921118

Reassessing Treatment Outcomes Following Immune-Related Adverse Events-Reply

Authors
Unger JM;Hershman DL
Journal / Conference
JAMA Oncology. 2026 Apr 23; . DOI: 10.1001/jamaoncol.2026.0785. Letter (reply RE 10.1001/jamaoncol.2025.5549 [PubID 6714])
Year
2026

Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) Into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report From the National Clinical Trials Network

Authors
Kovalchuk N;Simiele EA;LaRiviere M;Hiniker SM;Soike M;Han C;Wong J;Dandapani S;Kumar K;Parsons D;Teruel JR;Gerber NK;Guo B;Cherian S;Lim TY;Latifi K;Figura NB;Shrestha DK;Grecula J;Sim AJ;Parikh RR;Lo AC;Smith K;Plastaras JP;Xiao Y;Hoppe BS;Milgrom SA
Journal / Conference
International Journal of Radiation Oncology, Biology, Physics. 2026 Feb 17; S0360-3016(26)00388-3. DOI: 10.1016/j.ijrobp.2026.02.201. Online ahead of print
Year
2026
PMID
PMID41713515

Integrating Oncology APPs and Clinical Pharmacists into Clinical Cancer Research

Authors
Braun-Inglis C;Myers J;O‘Brien B;Kottschade L;Flannery M;Detroye AT;Elko T;Leatherwood A;Mader A;Wong SF;Foust M;Bakitas M;Benson AB;Berenberg JL;Primeaux B;Rosenzweig M;Demirhan K;Statler T;Vogel W
Journal / Conference
Journal of the National Cancer Institute. 2026 Apr 21; djag125. DOI: 10.1093/jnci/djag125.
Year
2026

Cancer statistics, 2026: Charting a course for a national cancer research agenda

Authors
Lara PN;Hershman DL
Journal / Conference
CA: A Cancer Journal for Clinicians. 2026 Jan 13; 76: e70061. DOI: 10.3322/caac.70061. editorial
Year
2026
Research Committee(s)
Multiple sites

Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignancies

Authors
Sim AJ;Hoppe BS;Ballas LK;Milgrom SA;Terezakis SA;Ha CS;Figura NB;Parikh RR;Grecula JC;Plastaras JP;Lo AC;Ryckman J;Flampouri S;Pinnix CC;Kelsey CR
Journal / Conference
Journal of the National Cancer Institute. 2026 Apr 7; djag112. DOI: 10.1093/jnci/djag112.
Year
2026
PMID
13249543
PMC
PMC41965109

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial

Authors
Shadman M;LeBlanc M;Rimsza L;Leonard JP;Smith SM;Li H;Friedberg JW
Journal / Conference
JAMA Oncology. 2026 Feb 26; e260042. DOI: 10.1001/jamaoncol.2026.0042. Online ahead of print
Year
2026
Research Committee(s)
Lymphoma
PMID
PMID41746629
Study Number(s)
S0016

Long-term follow-up of S0221, comparing alternative dose schedules of anthracycline/taxane therapy in early breast cancer

Authors
Ali A;Barlow WE;Moore HC;Hobday TJ;Isaacs C;Salim M;Albain KS;Chew HK;Burton GV;Srkalovic G;McGregor BA;Flaherty LE;Lew DL;Gralow JR;Hortobagyi GN;Sharma P;Pusztai L;Budd GT
Journal / Conference
JNCI Cancer Spectrum. 2026 Mar 14; pkag024. DOI: 10.1093/jncics/pkag024. Online ahead of print
Year
2026
Research Committee(s)
Breast
PMID
PMID41832961
Study Number(s)
S0221

Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609)

Authors
Chae YK;Othus M;Lyu J;Lee S;Paik S;Dietrich E;Jung CM;Chung LI;Patel S;Kurzrock R
Journal / Conference
Journal for ImmunoTherapy of Cancer. 2026 Mar 11; 14: e013260. DOI: 10.1136/jitc-2025-013260.
Year
2026
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID41819545
Study Number(s)
S1609

DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare Cancers

Authors
Patel SP;Othus M;Chae YK;Azenkot T;Alviz C;Threlkel S;Haymaker C;Streicher HZ;Magner CM;Chen HX;Sharon E;Ryan CW;Blanke CD;Kurzrock R
Journal / Conference
Annals of Oncology. 2026 Apr 15; S0923-7534(26)00142-0. DOI: 10.1016/j.annonc.2026.04.004. Epub ahead of print
Year
2026
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID41997295
Study Number(s)
S1609